USA - engelsk - NLM (National Library of Medicine)

merck sharp & dohme llc - letermovir (unii: 1h09y5wo1f) (letermovir - unii:1h09y5wo1f) - letermovir 240 mg - prevymis® is indicated for prophylaxis of cytomegalovirus (cmv) infection and disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant. prevymis is indicated for prophylaxis of cmv disease in adult kidney transplant recipients at high risk (donor cmv seropositive/recipient cmv seronegative [d+/r-]). - prevymis is contraindicated in patients receiving pimozide or ergot alkaloids: pimozide: concomitant administration of prevymis in patients receiving pimozide may result in increased concentrations of pimozide due to inhibition of cytochrome p450 3a (cyp3a) by letermovir, which may lead to qt prolongation and torsades de pointes [see warnings and precautions (5.1) and drug interactions (7.2, 7.3)] . ergot alkaloids: concomitant administration of prevymis in patients receiving ergot alkaloids may result in increased concentrations of ergot alkaloids (ergotamine and dihydroergotamine) due to inhibition of cyp3a by letermovir, which may lead to ergotism [see war

Taiwan - kinesisk - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

美商默沙東藥廠股份有限公司台灣分公司 台北市信義區信義路五段106號12樓 (86683720) - letermovir;;letermovir - 注射液劑 - 主成分 () ; letermovir (0818003900) mg; letermovir (0818003900) mg - letermovir - 適用於接受異體造血幹細胞移植(hsct)的成人cmv血清陽性受贈者[r+]，藉以預防巨細胞病毒(cmv)感染及相關疾病。

Serbia - serbisk - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

merck sharp & dohme d.o.o. - letermovir - film tableta - 240mg

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - letermovir, quantity: 480 mg - tablet, film coated - excipient ingredients: povidone; croscarmellose sodium; magnesium stearate; silicon dioxide; microcrystalline cellulose; carnauba wax; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow; iron oxide red - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - letermovir, quantity: 480 mg - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections; sodium chloride; hydroxypropylbetadex - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - letermovir, quantity: 240 mg - tablet, film coated - excipient ingredients: carnauba wax; croscarmellose sodium; magnesium stearate; silicon dioxide; microcrystalline cellulose; povidone; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - letermovir, quantity: 240 mg - injection, concentrated - excipient ingredients: water for injections; hydroxypropylbetadex; sodium chloride; sodium hydroxide - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

Den europeiske union - maltesisk - EMA (European Medicines Agency)

merck sharp & dohme b.v. - letermovir - infezzjonijiet taċ-ċitomegalovirus - antivirali għal użu sistemiku - prevymis huwa indikat għall-profilassi ta ' riattivazzjoni iċ-ċitomagalovirus (cmv) u l-marda f ' reċipjenti cmv-seroposittivi adulti [r +] tat-transplant taċ-ċelloli staminali haematopoietic ċelloli alloġeniċi (hsct). għandha tingħata kunsiderazzjoni għall-gwida uffiċjali dwar l-użu adattat ta ' aġenti antivirali.

Den europeiske union - tsjekkisk - EMA (European Medicines Agency)

merck sharp & dohme b.v. - letermovir - infekce cytomegaloviru - antivirotika pro systémové použití - prevymis je indikován k profylaxi cytomegalovirové (cmv) reaktivace a choroby u dospělých cmv séropozitivní příjemců [r +] transplantace alogenní hematopoetických kmenových buněk (hsct). pozornost by měla být věnována oficiálním doporučením pro správné používání antivirotik.

Den europeiske union - dansk - EMA (European Medicines Agency)

merck sharp & dohme b.v. - letermovir - cytomegalovirusinfektioner - antivirale midler til systemisk anvendelse - prevymis er indiceret til forebyggelse af cytomegalovirus (cmv) reaktivering og sygdom i voksen cmv-seropositive modtagere [r +] af en allogen hæmatopoietisk stamcelletransplantation (hsct). det bør overvejes at officielle vejledning om hensigtsmæssig brug af antivirale agenter.